Project Grant HT94252510498
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Evanston, IL 60208, USA
Similar Awards
This federal Project Grant award of $1,235,845.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research project led by the University of Illinois in Chicago. The project aims to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The award period runs from August 15, 2025 to August 14, 2028. The Military Medical Research and Development program funds...
The federal Project Grant award of $480,000.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports research by Northwestern University to investigate the role of translation heterogeneity in ovarian cancer. The research aims to uncover insights that can transform healthcare for military service members, veterans, and the broader public. The project has a performance period from September 1, 2024 to August 31, 2026. This award is...
The federal Project Grant award of $1,225,783 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA PET/CT in prostate cancer. This research, conducted by the University of Colorado-Denver, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This federal Project Grant award for $465,935.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research conducted by the University of Wisconsin - Madison to combine PSMA and BRD4 disruption approaches to overcome resistance in advanced prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical...
The Department of Defense's Defense Health Agency awarded Duke University a $1,344,946 Project Grant on September 1, 2023 through the Military Medical Research and Development program (CFDA 12.420). This grant supports a 3-year research project titled "Understanding Heterogeneity and Improving the Precision of Prostate Cancer Clinical Outcomes in the Modern Era." The research aims to advance understanding and treatment of prostate cancer, with a focus on improving clinical outcomes for...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,460,695.00 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to support the "Development and Validation of an Epigenomic Landscape and Novel Immunotherapy in Prostate Cancer Disparities" research project. The award period runs from September 1, 2025 to August 31, 2028. The funded research aims to...
The federal Project Grant award of $3,051,639.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant is titled "IMPROVING DELIVERY OF GERMLINE TESTING IN VETERANS WITH ADVANCED PROSTATE CANCER" and was awarded to the Northern California Institute for Research and Education, Inc. (NCIRE) on September 1, 2025, with a completion date of August 31, 2029. NCIRE, a non-profit research organization, will...
The Defense Health Agency awarded a $468,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research developing new therapeutic strategies to target TROP2 in aggressive prostate cancer. The two-year award beginning March 15, 2023 will fund research efforts to investigate medical solutions for prostate cancer on the battlefield and transform health care for service members and the public...
This federal Project Grant award, with a funding amount of $231,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the award will fund research to develop AI-designed de novo miniproteins coupled with small molecules to initiate immune cell-mediated eradication of...